ID Capan1M9 AC CVCL_0A59 DR cancercelllines; CVCL_0A59 DR Wikidata; Q54808592 RX PubMed=22109279; CC Population: Caucasian. CC Characteristics: Highly migratory cell subclone of Capan-1. CC Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Hemizygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:4039; FZD10; Simple; p.Asn54Lys (c.162C>A); Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:23671; GLT6D1; Simple; p.Trp198Ter (c.593G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:4593; GRM1; Simple; p.Tyr486Ter (c.1458C>A); Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Glu221Ter (c.661G>T); Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser343Ter (c.1028C>G); ClinVar=VCV000822036; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:25082; SMAP2; Simple; p.Ser255Ter (c.764C>G); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (from parent cell line). CC Derived from site: Metastatic; Liver; UBERON=UBERON_0002107. DI NCIt; C9120; Pancreatic ductal adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0237 ! Capan-1 SX Male AG 40Y CA Cancer cell line DT Created: 10-04-15; Last updated: 19-12-24; Version: 16 // RX PubMed=22109279; DOI=10.1007/s13577-011-0037-9; RA Ding, Qiang RA Yoshimitsu, Makoto RA Kuwahata, Taisaku RA Maeda, Koki RA Hayashi, Tomomi RA Obara, Toru RA Miyazaki, Yumi RA Matsubara, Shyuichiro RA Natsugoe, Shoji RA Takao, Sonshin RT "Establishment of a highly migratory subclone reveals that CD133 RT contributes to migration and invasion through epithelial-mesenchymal RT transition in pancreatic cancer."; RL Hum. Cell 25:1-8(2012). //